Premaitha Health PLC Holding(s) in Company (4052L)
July 18 2017 - 9:02AM
UK Regulatory
TIDMNIPT
RNS Number : 4052L
Premaitha Health PLC
18 July 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
------------------------------------------------------------------------------------------------------------
1a. Identity of the issuer Premaitha Health plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
-------------------------------------------------- --------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
------------------------------------------------------------------------------------------------------------
Non-UK issuer
----------------------------------------------------------------------------------------- -----------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------------------- -----------------
An acquisition or disposal of financial instruments X
----------------------------------------------------------------------------------------- -----------------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------------------- -----------------
Other (please specify)(iii) :
----------------------------------------------------------------------------------------- -----------------
3. Details of person subject to the notification obligation(iv)
Name Life Technologies Limited,
a company incorporated in
Scotland with company number
SC083107
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
------------------------------------------------------------------------------------------------------------
Name
-------------------------------------------------- --------------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------------- --------------------------------------------------------
5. Date on which the threshold 11 July 2017
was crossed or reached(vi)
:
-------------------------------------------------- --------------------------------------------------------
6. Date on which issuer notified 13 July 2017
(DD/MM/YYYY):
-------------------------------------------------- --------------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
------------------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
--------------------- ------------------------- ------------------- ---------------- -------------------
Resulting 25.92% (based 321,218,279
situation on current (based on
on the date share capital) current
on which and 20.88% share capital)
threshold (based on and 398,795,385
was crossed so-enlarged (based on
or reached share capital) so-enlarged
share capital)
--------------------- ------------------------- ------------------- ---------------- -------------------
Position 16.92% (based
of previous on current
notification share capital)
(if and 14.47%
applicable) (based on
so-enlarged
share capital).
--------------------- ------------------------- ------------------- ---------------- -------------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
---------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
------------------- ------------------------- ------------------ ------------------------------ ----------------
SUBTOTAL
8. A
--------------------- --------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
--------------------- ----------------------- ------------------ -------------------------------- ----------------
SUBTOTAL 8.
B 1
------------------ -------------------------------- ----------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable [Physical] 20,325,204 8.9% (based
2023 up to 11 on current
December share capital)
2023 and 7.07%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable [Physical] 17,094,018 7.5% (based
2023 up to 11 on current
December share capital)
2023 and 5.95%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable [Physical] 16,913,319 5.27% (based
2023 up to 11 on current
December share capital)
2023 and 4.5%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
Warrants 11 December Exercisable [Physical] 28,938,797 9% (based
2023 up to 11 on current
December share capital)
2023 and 7.26%
(based on
so-enlarged
share capital)
------------------- ------------------------- ---------------- --------------------- ----------- ----------------
SUBTOTAL 83,271,338 25.92% based
8.B.2 on current
share capital)
and 20.88%
(based on
so-enlarged
share capital)
--------------------- ----------- ----------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
--------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
------------------ ---------------- ----------------------- -----------------------
Thermo Fisher 25.92% based
Scientific Inc. on current share
capital) and
20.88% (based
on so-enlarged
share capital)
------------------ ---------------- ----------------------- -----------------------
Thermo Fisher 25.92% based
Scientific Life on current share
Holdings Limited capital) and
20.88% (based
on so-enlarged
share capital)
------------------ ---------------- ----------------------- -----------------------
10. In case of proxy voting, please identify:
--------------------------------------------------------------------------------------
Name of the proxy holder
------------------------------------ ------------------------------------------------
The number and % of voting
rights held
------------------------------------ ------------------------------------------------
The date until which the
voting rights will be held
------------------------------------ ------------------------------------------------
11. Additional information(xvi)
--------------------------------------------------------------------------------------
Place of completion London, United Kingdom
-------------------- -----------------------
Date of completion 11 July 2017
-------------------- -----------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWVURBKABAAR
(END) Dow Jones Newswires
July 18, 2017 09:02 ET (13:02 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024